Allegra Orthopaedics specialises in bringing innovation to market. Allegra’s principal product, the Active Total Knee, is such an example and has significantly improved the quality of life for many people globally.
The company is the global licensee to a synthetic biocompatible ceramic material, known as Sr-HT-Gahnite, initially developed by The University of Sydney. Sr-HT-Gahnite is currently under development. Preliminary studies indicate that devices have high bioactivity and bone growth onto scaffolds, as well as mechanical properties suitable for load bearing applications.
The company continues to build upon its extensive portfolio of patents. Allegra has built strong relationships with medical device companies and research organisations, such as The University of Sydney, University of NSW and The University of Adelaide, as well as Surgeon inventors/innovators. These collaborations have resulted in commercialisation of new medical devices in the market.
To find out more, contact us here.